Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-09 4:04 pm Sale |
2022-12-31 | 13G | MEI Pharma, Inc. MEIP |
UBS Oncology Impact Fund L.P. | 0 0.000% |
-506,893 (Position Closed) |
Filing History |
| 2021-02-16 08:32 am Purchase |
2020-12-31 | 13G | MEI Pharma, Inc. MEIP |
UBS Oncology Impact Fund L.P. | 506,893 9.000% |
194,393 (+62.21%) |
Filing History |
| 2021-01-19 4:33 pm Purchase |
2021-01-12 | 13D | Cullinan Oncology, Inc. CGEM |
UBS Oncology Impact Fund L.P. | 8,546,093 19.600% |
8,546,093 (New Position) |
Filing History |